scholarly journals Can a community pharmacy sleep assessment tool aid the identification of patients at risk of sleep disorders in the community: a pilot study

2012 ◽  
pp. 3 ◽  
Author(s):  
Krishneeta Kashyap ◽  
Lisa Nissen ◽  
Smith ◽  
Greg Kyle ◽  
Douglas
Keyword(s):  
At Risk ◽  
Pilot Study ◽  
Community Pharmacy ◽  
Sleep Disorders ◽  
Assessment Tool ◽  
Sleep Assessment ◽  
Patients At Risk

Psychoeducation with patients at-risk for schizophrenia—An exploratory pilot study

2009 ◽  
Vol 76 (1) ◽  
pp. 138-142 ◽  
Author(s):  
Marta Hauser ◽  
Marion Lautenschlager ◽  
Yehonala Gudlowski ◽  
Seza Özgürdal ◽  
Henning Witthaus ◽  
...  
Keyword(s):  
At Risk ◽  
Pilot Study ◽  
Patients At Risk

scholarly journals Periodontal Disease, Inflammatory Cytokines, and PGE2 in Pregnant Patients at Risk of Preterm Delivery: A Pilot Study

2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Catalina Latorre Uriza ◽  
Juliana Velosa-Porras ◽  
Nelly S. Roa ◽  
Stephani Margarita Quiñones Lara ◽  
Jaime Silva ◽  
...  
Keyword(s):  
At Risk ◽  
Pilot Study ◽  
High Risk ◽  
Periodontal Disease ◽  
Preterm Delivery ◽  
Inflammatory Cytokines ◽  
Inflammatory Responses ◽  
Low Risk ◽  
Prostaglandin E ◽  
Patients At Risk

Periodontal disease is an infection that, in pregnant women, can act as a risk factor for preterm delivery by increasing local and systemic inflammatory responses. Objective. To analyze the presence of periodontal disease, proinflammatory cytokines, and prostaglandin E2 (PGE2) in pregnant patients at high risk for preterm delivery. Materials and Methods. Pilot study for a case-control study. We included 46 pregnant patients (23 patients at risk of preterm delivery as cases and 23 patients without risk of preterm delivery as controls). We excluded patients who received periodontal treatment, antibiotics, or antimicrobials over the last 3 months as well as those with infections or diseases such as diabetes or hypercholesterolemia. The patients underwent a periodontal assessment, and their levels of cytokines (interleukin- [IL-] 2, IL-6, IL-10, and tumor necrosis factor- [TNF-] α) and prostaglandin E2 (PGE2) were quantified. Results. Patients with periodontal disease showed higher levels of cytokines (IL-2, IL-6, IL-10, and TNF-α) and PGE2. Patients at high risk for preterm birth showed higher IL levels compared with patients at low risk for preterm delivery. PGE2 increased with the severity of periodontal disease. PGE2 was higher in patients at low risk for preterm delivery, although this difference was not significant. Conclusion. Periodontal disease can increase the systemic inflammatory response as well as the levels of PGE2 and inflammatory cytokines in pregnant patients.

scholarly journals RestEaze: An Emerging Technology to Characterize Leg Movements During Sleep

2021 ◽  
Author(s):  
Justin Brooks ◽  
Cody Feltch ◽  
Janet Lam ◽  
Christopher Earley ◽  
Ryan Robucci ◽  
...  
Keyword(s):  
Sleep Disorders ◽  
Assessment Tool ◽  
Measurement Techniques ◽  
Standard Of Care ◽  
Measurement Unit ◽  
Periodic Leg Movements ◽  
Leg Muscles ◽  
Sleep Assessment ◽  
Sleep Measurement ◽  
Leg Movements

Abstract Several sleep disorders are characterized by periodic leg movements during sleep including Restless Leg Syndrome, and can indicate disrupted sleep in otherwise healthy individuals. Current technologies to measure periodic leg movements during sleep are limited. Polysomnography and some home sleep tests use surface electromyography to measure electrical activity from the anterior tibilias muscle. Actigraphy uses 3-axis accelerometers to measure movement of the ankle. Electromyography misses periodic leg movements that involve other leg muscles and is obtrusive because of the wires needed to carry the signal. Actigraphy based devices require large amplitude movements of the ankle to detect leg movements (missing the significant number of more subtle leg movements) and can be worn in multiple configurations precluding precision measurement. These limitations have contributed to their lack of adoption as a standard of care for several sleep disorders. In this study, we develop the RestEaze sleep assessment tool as an ankle-worn wearable device that combines capacitive sensors and a 6-axis inertial measurement unit to precisely measure periodic leg movements during sleep. This unique combination of sensors and the form-factor of the device addresses current limitations of periodic leg movements during sleep measurement techniques. Pilot data collected shows high correlation with polysomnography across a heterogeneous participant sample and high usability ratings. RestEaze shows promise in providing ecologically valid, longitudinal measures of leg movements that will be useful for clinicians, researchers, and patients to better understand sleep.

scholarly journals P131: Emergency department falls risk management screening tool comparison

CJEM ◽  
2016 ◽  
Vol 18 (S1) ◽  
pp. S121-S122
Author(s):  
R. Tomlinson ◽  
T. Yokota ◽  
P. Jaggi ◽  
C. Kilburn ◽  
D. Bakken ◽  
...  
Keyword(s):  
At Risk ◽  
Emergency Department ◽  
Risk Management ◽  
Fall Risk ◽  
Screening Tool ◽  
Assessment Tool ◽  
Tertiary Care ◽  
Screening Tools ◽  
Procedural Sedation ◽  
Patients At Risk

Introduction: Emergency Department (ED) fall risk screening has been newly implemented in Alberta based on Accreditation Canada requirements. Two existing inpatient tools failed to include certain ED risk conditions. One tool graded unconsciousness as no risk for falling, and neither considered intoxication or sedation. This led to the development of a new fall risk management screening tool, the FRM (Tool1). This study compared Tool1 with inpatient utilized Schmid Fall Risk Assessment Tool (Tool2) and the validated Hendrich II Fall Risk Model (Tool3). Methods: Patients (≥17 years old) in a tertiary care adult ED with any of the following; history of falling in the last 12 months, elderly/frail, incontinence, impaired gait, mobility assist device, confusion/disorientation, procedural sedation, intoxication/sedated, or unconscious were included. Forms were randomized to score patients using different paired screening tools: Tool1 paired with either Tool2 or Tool3. Percent agreement (PA) between the tools based on identification of a patient at either risk/no risk for falling; higher PA indicating more tool homogeneity. Results: A total of 928 screening forms were completed within our 8-week study period; 452 and 443 comparing Tool1 to Tool2 and Tool1 to Tool3, respectively. Thirty-two forms included only Tool1 scores, excluding them from comparative analysis. The average patient age (n=895) was 64.8±21.4 years. Tool1 identified 66.4% of patients at risk, whereas Tool2 and Tool3 identified only 19.2% and 31.4%, respectively. Tool1 and 2 had a PA of 50.2%, whereas Tool1 and Tool3 had a PA of 65.9%. Conclusion: The FRM tool had higher agreement with the validated assessment tool, identifying patients at risk for falling but better identified patients presenting with intoxication, need for procedural sedation and unconsciousness. The other tools generally miss these common ED conditions, putting these patients at risk. Validation and reliability assessments of the FRM tool are warranted.

scholarly journals EARLY DETECTION OF POOR ADHERENCE TO TREATMENT OF PEDIATRIC RHEUMATIC DISEASES: PEDIATRIC RHEUMATOLOGY ADHERENCE QUESTIONNAIRE - A PILOT STUDY

2019 ◽  
Vol 37 (2) ◽  
pp. 149-155
Author(s):  
Vanessa Bugni Miotto e Silva ◽  
Karine Yoshiye Kajiyama Okamoto ◽  
Luciana da Silva Ozaki ◽  
Claudio Arnaldo Len ◽  
Maria Teresa de Sande e Lemos Ramos Ascensão Terreri
Keyword(s):  
At Risk ◽  
Pilot Study ◽  
Early Detection ◽  
Medical Treatment ◽  
Rheumatic Diseases ◽  
Pediatric Rheumatology ◽  
Poor Adherence ◽  
Adherence To Treatment ◽  
Validity And Reliability ◽  
Patients At Risk

ABSTRACT Objective: To develop a questionnaire that allows the early detection of patients at risk for poor adherence to medical and non-medical treatment in children and adolescents with chronic rheumatic diseases. Methods: The Pediatric Rheumatology Adherence Questionnaire (PRAQ) was applied in recently diagnosed patients within a period of one to four months after confirmation of the rheumatic disease. After six months, the patients’ adherence to the medical and non-medical treatment was assessed. An internal consistency analysis was conducted to eliminate redundant questions in the PRAQ. Results: A total of 33 patients were included in the pilot study. Six months after the PRAQ had been applied, poor global adherence was observed in seven (21.2%) patients and poor adherence to medical treatment in eight (24.2%) patients. No correlation was observed between the PRAQ scores and the percentages of adherence, as well as the stratification for each index, except for a tendency to a correlation between socioeconomic index and poor adherence to medical treatment (p=0.08). A new PRAQ questionnaire with 25 of the 46 original questions was generated as a result of the reliability analysis. Conclusions: The usefulness of this questionnaire in clinical practice should be still evaluated. Due to the importance of a tool for the early detection of rheumatic patients at risk of poor adherence to treatment, the new PRAQ questionnaire should be reviewed and applied in a larger study to better define its validity and reliability.

Sign in / Sign up

Export Citation Format

Share Document